Bone Biologics Corp (BBLG)

NASDAQ
3.62
-0.17(-4.49%)
After Hours
3.50
-0.12(-3.31%)
- Real-time Data
  • Volume:
    99,896
  • Bid/Ask:
    3.50/3.79
  • Day's Range:
    3.50 - 3.80

BBLG Overview

Prev. Close
3.79
Day's Range
3.5-3.8
Revenue
-
Open
3.71
52 wk Range
3.32-18.75
EPS
-0.65
Volume
99,896
Market Cap
37.28M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
851,044
P/E Ratio
-
Beta
-
1-Year Change
-80.69%
Shares Outstanding
10,298,725
Next Earnings Date
01 Mar 2022
What is your sentiment on Bone Biologics Corp?
or
Market is currently closed. Voting is open during market hours.

Bone Biologics Corp Company Profile

Employees
2

Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. Its NELL-1/DBX is a combination product, which is an osteostimulative recombinant protein that provides target specific control over bone regeneration. The company is developing NELL-1/DBX Fusion Device for spinal fusion procedures in skeletally mature patients with degenerative disc disease at one level from L4-S1. Its platform technology has application in delivering enhanced outcomes in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine. The company has a license agreement with the UCLA Technology Development Group to develop and commercialize NELL-1 for spinal fusion applications. Bone Biologics Corporation was founded in 2004 and is headquartered in Burlington, Massachusetts.

Read More

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellStrong SellStrong SellStrong Sell
Technical IndicatorsSellSellStrong SellStrong SellStrong Sell
SummaryStrong SellStrong SellStrong SellStrong SellStrong Sell
    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.